openPR Logo
Press release

Rise in Cases of Cancer Boost Sale of Single-Cell Analysis

12-01-2022 05:27 AM CET | Health & Medicine

Press release from: P&S Intelligence

Rise in Cases of Cancer Boost Sale of Single-Cell Analysis

The single-cell analysis market garnered $3,839.0 million revenue in 2021, and it is projected to generate $10,304.3 million in 2030, rising at a rate of 11.6%.

Biomedicine and cell biology both use single-cell analysis as a crucial tool. Modern, superior optical technology provides the foundation for the creation and advancement of single-cell analysis. To date, a wide range of optical detection techniques, including super-resolution optical microscopy, optical tweezing, fluorescence imaging, dynamic light scattering, hyperspectral microscopy, and evanescent-wave sensing, have been utilized for single-cell analysis.

Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/single-cell-analysis-market/report-sample

Single-cell analysis is an effective technique used to study biological heterogeneity deeply and influence therapy choices. Lung cancer, breast cancer, brain cancer, bladder cancer, colon cancer, acute myeloid leukemia, and melanoma have all benefited from its use. Numerous fields, including immunology, prenatal diagnostics, neuroscience, embryogenesis, plant biology, and microbiology, use single-cell analysis extensively.

Inquire before purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=single-cell-analysis-market

In the single-cell analysis market, end customers include biotechnology firms, medical facilities, cell banks, IVF clinics, as well as research organizations. The hospital category holds the largest market share, and it is expected that it will continue to advance at a fast pace in the coming years. This is because hospitals offer their patients high-quality diagnostic services and a secure atmosphere.

Hence, demand for single-cell analysis will rise rapidly in years to come. This can be attributed to the rising prevalence of cancer and growing healthcare sectors in developing nations.

About P&S Intelligence

P&S Intelligence provides market research and consulting services to a vast array of industries across the world. As an enterprising research and consulting company, P&S believes in providing thorough insights on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness. P&S keeps the interest of its clients at heart, which is why the insights we provide are both honest and accurate. Our long list of satisfied clients includes entry-level firms as well as multi-million-dollar businesses and government agencies.

Contact:
P&S Intelligence
Phone: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rise in Cases of Cancer Boost Sale of Single-Cell Analysis here

News-ID: 2829610 • Views: 202

More Releases from P&S Intelligence

Australia E-Commerce in Automotive Aftermarket To Generate USD 3,822.2 Million b …
The Australia e-commerce in automotive aftermarket was worth around USD 1,503.5 million in 2022, and it will grow at a CAGR of 12.2% from 2022 to 2030, to touch USD 3,822.2 million by 2030, as per P&S Intelligence. This is due to the booming automotive aftermarket, escalating count of DIY customers, and convenience offered by online shopping platforms. Third-Party Retailers Account for Higher Product Sales The category of third-party retailers accounts for
North America Electric Scooters and Motorcycles Market Will Reach USD 2,348 Mill …
The North American electric scooters and motorcycles market was valued at USD 620 million in 2022, and this number is expected to reach USD 2,348 million by 2030, advancing at a CAGR of 18.10% during 2022-2030, according to P&S Intelligence. This development can be ascribed to supportive government initiatives, from both federal and state levels. To encourage the acceptance of electric vehicles, the government is offering tax rebates and subsidies
Exploring the Growth of the Hybrid Electric Car Market
Before we move to the various advantages of hybrid electric cars, let's first understand their mechanism. A hybrid vehicle comprises both the internal combustion engine and electric motor. The batteries provide power to the motor, facilitating the rotation of the wheels either on their own or by supplementing the engine while accelerating. To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/hybrid-electric-car-market/report-sample Why Is It Hybrid before Electric? Since hybrid electric cars are a
Autonomous Mobile Robots Market To Reach USD 10,979 Million by 2030
The total size of the autonomous mobile robots market was USD 3,148 million in 2022, and it will reach a value of USD 10,979 million by 2030, advancing at rate 16.90% in the years to come, as per a report by a market research company, P&S Intelligence. The logistics category had the largest share of revenue, of about 29% in the past. These robots are chiefly installed for transportation of goods

All 5 Releases


More Releases for Biomedicine

Biopharmaceuticals and Biomedicine Market Size Report, 2020
Biomedicine Market The annual growth rate of world biomedicine market has been outpacing that of the overall pharmaceutical market in recent years and this trend will continue in the coming years with a steady 10.4% growth per annum by 2020. In particular, China’s biomedicine market is expected to grow at an even higher rate (15% annually) over the forecast 2015-2020 period, driven by increasing and aging population, government initiatives and favorable
Marine Biomedicine Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Marine Biomedicine Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. The report contains 124 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability. Click to view the full report TOC, figure and tables: https://www.globalinforesearch.com/global-marine-biomedicine-market_p103859.html Marine biodiversity is a rich source of medicines
Influx of Technologically Advanced Biopharmaceutical and Biomedicine Drives the …
Biopharmaceuticals has emerged as one of the key segments with immense growth potential in the healthcare sector. Rising demand for effective treatment and rise in per capita healthcare expenditure has led to double digit revenue growth for industry players in the recent past. The industry offers lucrative growth opportunities, since most of these products still have low penetration rate. The market is expected to gain further traction, with evolving treatment
Biopharmaceuticals and Biomedicine Market - Trends, Opportunity Analysis, 2016-2 …
Changing healthcare landscape and adoption of alternative business operating model to drive growth of North America biopharmaceutical and biomedicine market The biopharmaceutical and biomedicine market report covers analysis across regions – North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Geographically, North America accounted for over 52% share of global industry revenue in 2015. However, the region is expected to lose significant market share to emerging markets of Asia Pacific
Biopharmaceuticals and Biomedicine Market - Rapid Technical Innovation
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Biopharmaceuticals and Biomedicine Industry. Market Definition: Biopharmaceuticals has come across as one of the major segments commanding huge growth potential within the healthcare field. The high demand for effective treatment and increase in per capita healthcare expenditure has resulted in double digit revenue growth for market
Biomedicine & Bioscience Laboratories Ltd
Biomedicine & Bioscience Laboratories Ltd is a laboratory chemicals and reagents manufacturing company and a testing laboratory. Biomedicine & Bioscience Laboratories Ltd provides a broad range of laboratory chemicals and reagents to the UK/Europe and worldwide industry in order that the global laboratory industry, healthcare industries and related industries can enhance, excellence, and keep on advancing in their professionals activities. Biomedicine & Bioscience Laboratories Ltd (BLC) is further dedicated to